TABLE 1.
Patient and Disease Characteristics in NeuroBlate (Monteris Medical) vs Biopsy Group (n [%]) or Median (Range)
| NeuroBlate | Biopsy | ||
|---|---|---|---|
| Factor | (n = 24) | only (n = 24) | P value |
| Gender | .72 | ||
| Female | 12 (50.0%) | 10 (41.7%) | |
| Male | 12 (50.0%) | 14 (58.3%) | |
| Agea | 54 (34-75) | 64(32, 85) | 1.00 |
| <70 yr | 17 (70.8%) | 18 (75.0%) | |
| ≥70 yr | 7 (29.2%) | 6 (25.0%) | |
| Location | 1.00 | ||
| Lobar | 11 (45.8%) | 11 (45.8%) | |
| Deep | 13 (54.2%) | 13 (54.2%) | |
| Volume (cc) | 9.3 (1.3-62.8) | 8.2 (0.9-187) | 1.00 |
| < 11 cc | 16 (66.7%) | 16 (66.7%) | |
| ≥ 11 cc | 8 (33.3%) | 8 (33.3%) | |
| Ki-67 | .57 | ||
| <20% | 8 (42%) | 5 (28%) | |
| >20% | 11 (58%) | 13 (72%) |
aAt time of LITT for NeuroBlate patients; at diagnosis for biopsy only patients